share_log

HC Wainwright & Co. Reiterates Buy on InflaRx, Maintains $9 Price Target

Benzinga ·  Sep 12, 2023 06:10

HC Wainwright & Co. analyst Edward White reiterates InflaRx (NASDAQ:IFRX) with a Buy and maintains $9 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment